About the Strata Rx Conference
Why You Should Attend | Experience Strata | Who Should Attend Strata Rx | Program Committee
This first-of-its-kind conference focuses on using big data to enable personalized and predictive medicine in order to achieve better patient outcomes and lower costs. This can be done by harnessing the explosion of healthcare data---from next-generation DNA sequencing to electronic health records, longitudinal claims data, and personal health device data (mobile health/quantified self).
The time for this is now: the integration of multiple types of data from different parts of the healthcare system represents a major opportunity for disruptive solutions. At Strata Rx, industry leaders and innovators will share what they’ve learned about parsing this data with next-generation analytics tools in order to better understand the drivers of patient health outcomes and care costs.
Speakers and stakeholders involved in this conference represent the leaders in the health insurance industry, the pharmaceutical and biotech industries, academic institutions, hospitals, government, and patient advocacy groups. This will be the first conference to bring together the leaders who are using data to transform healthcare across new product development (pharmaceutical drugs and medical devices), the delivery of care, and paying for that care.
Why You Should Attend
Strata is becoming the defining conference for the layered world of everything data.
- Be the first to understand how you can leverage the promise of this huge change, and survive the resulting disruption
- Find new ways to leverage your data assets across industry segments and disciplines
- Learn how to take big data from pet project to real business application
- Understand the training, hiring, and career opportunities for healthcare professionals with data analytics skills
- Meet face-to-face with other innovators and thought leaders
Experience Strata Rx
- Dozens of sessions that explore the latest advances, case studies, and best practices
- Networking opportunities with hundreds of other industry leaders, data professionals, designers, and developers
- A vibrant "hallway track" for attendees, speakers, journalists, and vendors to debate and discuss important issues
- Fun evening events, receptions, and more, giving you more face time with attendees and speakers
Who Should Attend Strata Rx
The O'Reilly Strata Rx Conference is for data and healthcare professionals, including:
- Pharmaceutical and biotech leaders
- CEOs, CMOs, CIOs, CTOs, and other health insurance executives
- Patient advocacy professionals
- Hospital administrators
- Government innovators
- Product managers
- Researchers and academics
- Data-driven designers, healthcare journalists, and anthropologists
- VCs and investors
- Innovators, start-up founders, and disruptors
Strata attendees have job titles including:
Bioinformatics scientist; Business Process Analyst; CEO, COO, Chief Architect, Chief Creative Officer, Chief Data Officer, Chief Data Scientist, CIO/CTO, Computational Information Designer, Data Architect, Mining Engineer, Modeling Manager, Ops Manager; Director of Analytics, Business Development, Core Engineering, Consumer Web Development, International Research, Predictive Analytics and Optimization, Product Planning; Enterprise Architect; Founder; Manager of IT Metrics, Product Development, Technology Innovation, Web Systems; Managing Director; Partner; President; Principal; Principal Analyst,Engineer, Staff Research Engineer; Product Architect; Quantitative Analyst; Quantitative User Experience Researcher; Research Engineer; Research Systems Analyst; Search Quality Analyst; Senior Analytic Scientist, Director, Information Architect, Product Manager, Research Systems Analyst, Software Engineer, Statistician, Systems Engineer, Technologist; Software Architect and Development Manager; Solutions Architect; Sr. Technical Manager - Data Warehouse; User Experience Product Manager; Venture Partner; Vice Presidents of Data Analytics, Business Intelligence, Numerics, Engineering, R&D, Platform, Business Development/Strategy, Marketing Analytics, and Product Development; and more.
Our conferences bring together representatives from companies and organizations such as:
1010data, 10gen/MongoDB, AARP, Acxiom, Alliance Health, Amazon, American Public Media, American Socity of Health-System Pharmacists, Analog Software, Anthem Blue Cross, AOL, Apple, Artemis Financial Group, Athena Health, ATT Interactive, Bayer Healthcare, Bioanalytical Computing, Booz Allen Hamilton, Bristol-Myers Squibb, California Watch, Calpont, Canon, Capital IQ, CareerBuilder.com, Carfax, Center for Investigative Reporting, Chevron, Cisco Systems, clearhealth inc., Clear Capital, Cloudera, Couchbase, Cray, DataMeer, DataRaker, DataSift, DataStax, Department of Health and Human Services, Digital Reasoning, eHealth Systems Chile, EMC, Esri, Facebook, Factual, Federal Reserve Board, Gartner, Global Health Initiatives, Inc., Google, Greylock Partners, Groupon, Health Informatics Public Private Partnership, HealthTech Capital, Healthspottr, HPCC Systems, IBM, IntraHealth International, John Muir Health, Kaiser Permanente, London Health Sciences Center, Macmillan, MarkLogic, McKesson Pharmaceutical, McLaren Applied Technologies, Merck & Co., Microsoft, Microsoft, Health Solutions Group, Ministry of Health Singapore, Motorola Mobility, National Institute of Health, National Instruments Corporation, NetApp, Netflix, New Scientist, Nokia, Oracle, Orange Labs, Orbitz Worldwide, PatientsLikeMe, Pentaho, Pfizer, Philips Healthcare, Public Library of Sciences, Quest Software, Qwest, Rackspace Hosting, Raytheon/JPL, Relay Health, Sephora, Shared Learning, Shopzilla, Starcom Worldwide, Survey Sampling International, SVB Financial Group, Tenzing Health, Teradata Aster, Texas Department of State Health Services, The Dartmouth Institute for Health Policy and Clinical Practice, Thomson Reuters, TIS R&D Center, Trident Capital, U.C. Berkeley, UCLA, United Health Group, Universal Pictures International, US Department of Health and Human Services, USDA - Health Inspection Service, Venrock, Veterans Health Administration, VMWare, Weather Trends International, Webster Clay, Wells Fargo, World Health Organization, WorldWildeHealth.org, Zephyr Health Inc., and more.
Colin is the CEO and co-founder of GNS Healthcare, a pioneer in big data analytics in personalized medicine and healthcare. Colin is a frequent speaker at international scientific and industry conferences and has appeared in numerous publications and television segments including The Wall Street Journal, CNBC Morning Call, Nature, Forbes, Wired, and The Economist. He serves as CEO and Chairman of GNS Healthcare's parent company Via Science, and as chairman of the board of Fina Technologies, a subsidiary of Via Science that applies next-generation artificial intelligence technology to real-time financial trading. He also serves on the board of directors of AesRx, a biopharmaceutical company dedicated to the development of a new treatment for sickle cell disease, and writes the Healthcare 2020 blog for Forbes. In 2004, Colin was named to MIT Technology Review's TR100 list of the top innovators in the world under the age of 35. He graduated from Virginia Tech with a degree in physics and earned master's degrees in physics from McGill University and Cornell University.
Julie works at O'Reilly Media as Content Editor for Strata. She is co-author of Beautiful Visualization and Designing Data Visualizations. She finds beauty in discovering new ways to understand complex systems, and so enjoys connecting people and ideas across verticals and traditional silos, and is particularly drawn to the visual medium as a way to understand data. Julie holds a Master's degree in Political Science (International Relations) from Rutgers University. She lives in NYC, where she cooks, reads, and practices yoga.
Dr. Barker recently joined ASU to plan and direct efforts in transformative knowledge networks – specifically directed toward addressing major problems in healthcare. The Transformative Healthcare Networks initiative (THN) will serve as a foundation for the development of new research models that leverage convergent knowledge, innovative teams and novel funding approaches to better prevent and treat acute and chronic diseases. She also serves as Co-Director of a major ASU initiative in complex adaptive systems research.
Alexis Borisy is a successful biotechnology entrepreneur with 20 years of experience building and operating innovative science based organizations. Alexis joined Third Rock Ventures in 2009 as an Entrepreneur-in-Residence and was named Partner in 2010. Alexis focuses on the formation, development and strategy of new companies, including Warp Drive Bio for which he serves as CEO.
Professor Davenport is a Visiting Professor at Harvard Business School. He has taught at Babson College, University of Chicago, Dartmouth's Tuck School of Business, and the University of Texas at Austin. He has directed research centers at Accenture, Ernst & Young, McKinsey & Company, and CSC Index.
Vincent is the Vice President and Managing Director of The Health Economics
and Outcomes Research Institute (THEORI) at the Greater New York Hospital
Association (GNYHA). Vincent focuses on the acquisition, analysis, and
visualization of health care data and develops custom data tools to promote
quality improvement in large hospital collaboratives. Prior to joining
GNYHA, he served as a senior policy analyst at a New York State commission
responsible for reconfiguring New York State’s health care delivery system.
He has also worked with not-for-profit and patient advocacy organizations,
public relations firms, and corporate clients as a health care researcher at
Harris Interactive. Vincent holds a Master's degree in Political Science
from the University of Rochester.
Felix Frueh is President of the Medco Research InstituteTM, where he leads Medco's peer-reviewed research initiatives and collaborations in the areas of personalized medicine, comparative effectiveness and chronic conditions, examining how the newest developments in science can improve the safety and efficacy of prescription drug care. Frueh joined Medco in 2008 as vice president of Medco's personalized medicine research and development organization.
Bill Geary focuses his investing primarily on healthcare and has been with North Bridge since the firm's founding in 1994. He has served on the Boards of numerous market-leading companies and has played an invaluable role in helping nearly all North Bridge investments establish themselves as businesses. Previously, Bill was a Partner at Hambro International Equity Partners. Prior to that, he was Chief Financial Officer of MathSoft, an applications software start-up that subsequently went public on the NASDAQ and was later acquired by Parametric Technology Corporation [NASDAQ: PMTC]. Nearly 25 years ago, while negotiating the terms of a first round investment in MathSoft as its CFO, he sat on opposite sides of the table from Rich D'Amore, one of his current North Bridge colleagues an exchange enlivened by the early portable computer Bill had lugged along, which modeled every proposition on the spot and taught Rich his first lesson in the artful use of technology.
Kathy Giusti is the Founder and Chief Executive Officer of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC). Together, the two organizations have developed innovative models that serve to rapidly break down barriers slowing multiple myeloma research and accelerate the development of next-generation treatments. Chief among these are an integrated clinical network of academic centers that collaboratively conduct early-stage clinical trials, as well as a state-of-the-art tissue bank that has advanced the science of biobanking and genomic studies and provides a foundation for the organizations’ pursuit of personalized medicine.
Prior to founding the MMRF, Giusti was a pharmaceutical executive at G.D. Searle & Co., and previously held positions at Merck & Co. and the Gillette Company. Giusti, a multiple myeloma patient, was most recently named to the 2011 TIME 100 List of the world’s most influential people—a recognition she received for the progress she has made in accelerating the way research and drug development are conducted and, ultimately, dramatically improving the outlook for patients with multiple myeloma and other cancers.
Paul Levy, former CEO of Beth Israel Deaconess Medical Center, is an advocate for patient-driven care who writes a blog about health care issues entitled "Not Running a Hospital". Paul is also the author of "Goal Play! Leadership lessons from the soccer field".
Rodrigo Martinez is passionate about the way our understanding of how life works at the genetic, cellular, molecular and systemic levels is transforming products, business, and industries. As Life Sciences Chief Strategist at IDEO and member of the Health & Wellness practice, he tackles some of the most interesting challenges in health care, life sciences, and the emerging wellness space.
Carol McCall is responsible for guiding the development of GNS Healthcare's strategies and aligning them with key initiatives, investments and offerings.
Carol is a health actuary with a background in innovation, predictive analytics and health services design. Her specialties are creating novel computational approaches that leverage 'big data' in healthcare and designing services and business models that expand on the traditional notions of health, care, community and sustainability. Most recently, Carol served as Chief Innovation Officer at Tenzing Health, a subsidiary of Vanguard Health Systems, where she merged creative analytic approaches with innovations in health services that extended the dimensions of care, improved people's health, and dramatically reduced their healthcare costs.
DJ is the "Data Scientist in Residence" at Greylock Partners.
Previously he was the Chief Product Officer for Color and the Chief Scientist at the LinkedIn Corporation, leading the Analytics and Data Teams. Some of the products shipped include, People You May Know, Who's Viewed My Profile, Talent Match, Skills, and Career Explorer. He has held roles at Skype, PayPal, and eBay. As was a member of the faculty at the University of Maryland, he helped start a major research initiative on numerical weather prediction. As an AAAS Science & Technology Policy Fellow for the Department of Defense, Dr. Patil directed new efforts to leverage social network analysis and the melding of computational and social sciences to anticipate emerging threats to the US. He has also co-chaired a major review of US efforts to prevent bioweapons proliferation in Central Asia and co-founded the Iraqi Virtual Science Library (IVSL).
Eric is currently Chief Information Officer and Chief Scientist (Informatics) at the U.S. Food and Drug Administration. In this new role, Eric is responsible for modernizing and enhancing the IT capabilities as well as the in silico scientific capabilities at FDA.
Prior to FDA, Eric was Senior Vice President of R&D Information Technology at Johnson & Johnson Pharmaceuticals R&D and was a member of the Corporate Office of Science and Technology. During his thirteen years at J&J, Eric also held the posts of Vice President R&D Informatics, Vice President and Chief Information Officer, Director of Research Information Technology as well as assistant Director and Director of Drug Discovery Research prior to his current role. Before joining J&J, Eric was the Group leader of Scientific Computing at ArQule Inc. and he began his professional career with the Army Corps of Engineers.
Eric Schadt, PhD, is Director of the Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences and the Jean C. and James W. Crystal Professor of Genomics.
Dr. Schadt is an expert on the generation and integration of very large-scale sequence variation, molecular profiling and clinical data in disease populations for constructing molecular networks that define disease states and link molecular biology to physiology. His research has provided novel insights into what is needed to master diverse, large-scale data collected on normal and disease populations in order to elucidate the complexity of disease and make more informed decisions in the drug discovery arena. He has contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes and obesity, which have been widely published in leading scientific journals.
David is a practicing Emergency Medicine physician with an entrepreneurial slant. He came up with the idea of SnapHealth back in 2003 but it wasn't until now that the cost of health insurance and what physicians were getting reimbursed diverged so far that the concept made sense.
David is a Northwestern University graduate; attended medical school at The Ohio State University and specialized in Emergency Medicine At George Washington University.